Preprint Article Version 1 This version is not peer-reviewed

Pretargeted Imaging with Gallium-68 – Improving the Binding Capability by Increasing the Number of Tetrazine Motifs

Version 1 : Received: 3 September 2018 / Approved: 3 September 2018 / Online: 3 September 2018 (15:55:44 CEST)

A peer-reviewed article of this Preprint also exists.

Summer, D.; Mayr, S.; Petrik, M.; Rangger, C.; Schoeler, K.; Vieider, L.; Matuszczak, B.; Decristoforo, C. Pretargeted Imaging with Gallium-68—Improving the Binding Capability by Increasing the Number of Tetrazine Motifs. Pharmaceuticals 2018, 11, 102. Summer, D.; Mayr, S.; Petrik, M.; Rangger, C.; Schoeler, K.; Vieider, L.; Matuszczak, B.; Decristoforo, C. Pretargeted Imaging with Gallium-68—Improving the Binding Capability by Increasing the Number of Tetrazine Motifs. Pharmaceuticals 2018, 11, 102.

Journal reference: Pharmaceuticals 2018, 11, 102
DOI: 10.3390/ph11040102

Abstract

Among extensive studies on click chemistry the inverse electron-demand Diels-Alder reaction between 1,2,4,5-tetrazine (Tz) and trans-cyclooct-2-en (TCO) has gained increasing attraction due to its exceptionally fast reaction kinetics and high selectivity for in vivo pretargeting applications including PET imaging. The facile two-step approach utilizing TCO-modified antibodies as targeting structures has not made it into clinic though as the increase in blood volume from mice to human seems to be the major limitation. This study aimed to show if the design of multimeric Tz-ligands by chelator scaffolding can improve the binding capacity and may lead to enhanced PET imaging with gallium-68. For this purpose we utilized the macrocyclic siderophore Fusarinine C (FSC) which allows to conjugate up to three Tz-residues due to three primary amines available for site specific modification. The resulting mono- di- and trimeric conjugates were radiolabelled with gallium-68 and characterized in vitro (logD, protein binding, stability, binding towards TCO modified rituximab (RTX)) and in vivo (biodistribution- and imaging studies in normal BALB/c mice using a simplified RTX-TCO tumour surrogate). The 68Ga-labelled FSC-based Tz-ligands showed suitable hydrophilicity, high stability, high targeting specificity and the binding capacity to RTX-TCO was increased by the grade of multimerization. Corresponding in vivo studies showed a multimerization typical profile but generally suitable pharmacokinetics with low accumulation in non-targeted tissue. Imaging studies in RTX-TCO tumour surrogate bearing BALB/c mice confirmed this trend and revealed improved targeting by multimerization as increased accumulation in RTX-TCO positive tissue was observed.

Subject Areas

pretargeting; Fusarinine C; rituximab; click chemistry; multimerization; PET; gallium-68

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.